BACKGROUND: Injection drug use is a growing public health crisis along the U.S.-Mexican border and rising rates of blood-borne infections highlight the pressing need for harm reduction interventions. We explored the acceptability and feasibility of such interventions in Tijuana, a city adjacent to San Diego, California. METHODS: Using in-depth qualitative interviews conducted from August 2006-March 2007 with 40 key stakeholders - pharmacists, legal professionals, health officials, religious officials, drug treatment providers, and law enforcement personnel - we explored the acceptability and feasibility of interventions to reduce drug-related harm in Tijuana, Mexico. Interviews were taped with consent, transcribed verbatim, and translated. Content analysis was conducted to identify themes which included barriers, structural limitations, and suggestions for implementation. RESULTS: Topics included acceptance and feasibility of needle exchange programmes (NEPs), syringe vending machines, and safer injection facilities (SIFs), structural barriers and suggestions for implementation. Of these interventions, NEPs were deemed the most acceptable (75%); however, only half believed these could be feasibly implemented, citing barriers involving religion, police, and lack of political will, public awareness, and funding. CONCLUSIONS: Increasing HIV infection rates among injection drug users in Tijuana have prompted interest in public health responses. Our results may assist policy strategists in implementing social-structural interventions that will help create enabling environments that facilitate the scale-up and implementation of harm reduction in Tijuana.
BACKGROUND: Injection drug use is a growing public health crisis along the U.S.-Mexican border and rising rates of blood-borne infections highlight the pressing need for harm reduction interventions. We explored the acceptability and feasibility of such interventions in Tijuana, a city adjacent to San Diego, California. METHODS: Using in-depth qualitative interviews conducted from August 2006-March 2007 with 40 key stakeholders - pharmacists, legal professionals, health officials, religious officials, drug treatment providers, and law enforcement personnel - we explored the acceptability and feasibility of interventions to reduce drug-related harm in Tijuana, Mexico. Interviews were taped with consent, transcribed verbatim, and translated. Content analysis was conducted to identify themes which included barriers, structural limitations, and suggestions for implementation. RESULTS: Topics included acceptance and feasibility of needle exchange programmes (NEPs), syringe vending machines, and safer injection facilities (SIFs), structural barriers and suggestions for implementation. Of these interventions, NEPs were deemed the most acceptable (75%); however, only half believed these could be feasibly implemented, citing barriers involving religion, police, and lack of political will, public awareness, and funding. CONCLUSIONS: Increasing HIV infection rates among injection drug users in Tijuana have prompted interest in public health responses. Our results may assist policy strategists in implementing social-structural interventions that will help create enabling environments that facilitate the scale-up and implementation of harm reduction in Tijuana.
Authors: D Vlahov; D C Des Jarlais; E Goosby; P C Hollinger; P G Lurie; M D Shriver; S A Strathdee Journal: Am J Epidemiol Date: 2001-12-15 Impact factor: 4.897
Authors: Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee Journal: Soc Sci Med Date: 2005-03-19 Impact factor: 4.634
Authors: Evan Wood; Thomas Kerr; Mark W Tyndall; Ruth Zhang; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner Journal: Addiction Date: 2007-09 Impact factor: 6.526
Authors: Kimberly C Brouwer; Steffanie A Strathdee; Carlos Magis-Rodríguez; Enrique Bravo-García; Cecilia Gayet; Thomas L Patterson; Stefano M Bertozzi; Robert S Hogg Journal: J Urban Health Date: 2006-03 Impact factor: 3.671
Authors: Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: Oralia Loza; Thomas L Patterson; Melanie Rusch; Gustavo A Martínez; Remedios Lozada; Hugo Staines-Orozco; Carlos Magis-Rodríguez; Steffanie A Strathdee Journal: Addiction Date: 2010-04-27 Impact factor: 6.526
Authors: Steffanie A Strathdee; Carlos Magis-Rodriguez; Vickie M Mays; Richard Jimenez; Thomas L Patterson Journal: Ann Epidemiol Date: 2012-06 Impact factor: 3.797
Authors: Angela M Robertson; Remedios Lozada; Alicia Vera; Lawrence A Palinkas; José Luis Burgos; Carlos Magis-Rodriguez; Gudelia Rangel; Victoria D Ojeda Journal: Qual Health Res Date: 2011-09-13
Authors: Angela M Robertson; Alicia Y Vera; Manuel Gallardo; Robin A Pollini; Thomas L Patterson; Patricia Case; Lucie Nguyen; Steffanie A Strathdee Journal: Am J Addict Date: 2010 Jul-Aug
Authors: R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee Journal: Int J Tuberc Lung Dis Date: 2009-05 Impact factor: 2.373
Authors: Danielle M Smith; Dan Werb; Daniela Abramovitz; Carlos Magis-Rodriguez; Alicia Vera; Thomas L Patterson; Steffanie A Strathdee Journal: Am J Addict Date: 2016-01-14
Authors: Morgan M Philbin; Remedios Lozada; María Luisa Zúñiga; Andrea Mantsios; Patricia Case; Carlos Magis-Rodriguez; Carl A Latkin; Steffanie A Strathdee Journal: Harm Reduct J Date: 2008-11-20